396 related items for PubMed ID: 30388594
1. Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression.
Ter Horst DM, Schene AH, Figueroa CA, Assies J, Lok A, Bockting CLH, Ruhé HG, Mocking RJT.
Psychoneuroendocrinology; 2019 Feb; 100():203-212. PubMed ID: 30388594
[Abstract] [Full Text] [Related]
2. DHEAS and cortisol/DHEAS-ratio in recurrent depression: State, or trait predicting 10-year recurrence?
Mocking RJ, Pellikaan CM, Lok A, Assies J, Ruhé HG, Koeter MW, Visser I, Bockting CL, Olff M, Schene AH.
Psychoneuroendocrinology; 2015 Sep; 59():91-101. PubMed ID: 26036454
[Abstract] [Full Text] [Related]
3. Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression.
Mocking RJ, Ruhé HG, Assies J, Lok A, Koeter MW, Visser I, Bockting CL, Schene AH.
Psychoneuroendocrinology; 2013 Sep; 38(9):1607-17. PubMed ID: 23465556
[Abstract] [Full Text] [Related]
4. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
Mocking RJ, Verburg HF, Westerink AM, Assies J, Vaz FM, Koeter MW, Ruhé HG, Schene AH.
Psychoneuroendocrinology; 2015 Sep; 59():1-13. PubMed ID: 26010860
[Abstract] [Full Text] [Related]
5. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression.
Lok A, Mocking RJ, Ruhé HG, Visser I, Koeter MW, Assies J, Bockting CL, Olff M, Schene AH.
Psychoneuroendocrinology; 2012 Jul; 37(7):892-902. PubMed ID: 22094110
[Abstract] [Full Text] [Related]
6. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
Salvat-Pujol N, Labad J, Urretavizcaya M, de Arriba-Arnau A, Segalàs C, Real E, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Menchón JM, Soria V.
Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
[Abstract] [Full Text] [Related]
7. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
Sorgdrager FJH, Doornbos B, Penninx BWJH, de Jonge P, Kema IP.
J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
[Abstract] [Full Text] [Related]
8. Morning salivary dehydroepiandrosterone (DHEA) qualifies as the only neuroendocrine biomarker separating depressed patients with and without prior history of depression: An HPA axis challenge study.
Agorastos A, Heinig A, Sommer A, Wiedemann K, Demiralay C.
J Psychiatr Res; 2023 May; 161():449-454. PubMed ID: 37059029
[Abstract] [Full Text] [Related]
9. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder.
Hardeveld F, Spijker J, Vreeburg SA, Graaf RD, Hendriks SM, Licht CM, Nolen WA, Penninx BW, Beekman AT.
Psychoneuroendocrinology; 2014 Dec; 50():62-71. PubMed ID: 25179322
[Abstract] [Full Text] [Related]
10. Attenuated DHEA and DHEA-S response to acute psychosocial stress in individuals with depressive disorders.
Jiang X, Zhong W, An H, Fu M, Chen Y, Zhang Z, Xiao Z.
J Affect Disord; 2017 Jun; 215():118-124. PubMed ID: 28319688
[Abstract] [Full Text] [Related]
11. The predictive value of cortisol levels on 2-year course of depression in older persons.
Kabia FM, Rhebergen D, van Exel E, Stek ML, Comijs HC.
Psychoneuroendocrinology; 2016 Jan; 63():320-6. PubMed ID: 26546785
[Abstract] [Full Text] [Related]
12. Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression.
Labad J, Soria V, Salvat-Pujol N, Segalàs C, Real E, Urretavizcaya M, de Arriba-Arnau A, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Alonso P, Menchón JM.
Psychoneuroendocrinology; 2018 Jul; 93():20-28. PubMed ID: 29684711
[Abstract] [Full Text] [Related]
13. Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes--the SMART Medea study.
Gerritsen L, Comijs HC, van der Graaf Y, Knoops AJ, Penninx BW, Geerlings MI.
Biol Psychiatry; 2011 Aug 15; 70(4):373-80. PubMed ID: 21439552
[Abstract] [Full Text] [Related]
14. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.
Arch Gen Psychiatry; 2009 Jun 15; 66(6):617-26. PubMed ID: 19487626
[Abstract] [Full Text] [Related]
15. Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder.
Pochigaeva K, Druzhkova T, Yakovlev A, Onufriev M, Grishkina M, Chepelev A, Guekht A, Gulyaeva N.
Metab Brain Dis; 2017 Apr 15; 32(2):577-583. PubMed ID: 28064407
[Abstract] [Full Text] [Related]
16. Lower cortisol levels predict recurrence in remitted patients with recurrent depression: a 5.5 year prospective study.
Bockting CL, Lok A, Visser I, Assies J, Koeter MW, Schene AH, DELTA study group.
Psychiatry Res; 2012 Dec 30; 200(2-3):281-7. PubMed ID: 22503382
[Abstract] [Full Text] [Related]
17. Increased symptoms of anxiety and depression in prepubertal girls, but not boys, with premature adrenarche: associations with serum DHEAS and daily salivary cortisol concentrations.
Marakaki C, Pervanidou P, Papassotiriou I, Mastorakos G, Hochberg Z, Chrousos G, Papadimitriou A.
Stress; 2018 Nov 30; 21(6):564-568. PubMed ID: 29916751
[Abstract] [Full Text] [Related]
18. Attachment impacts cortisol awakening response in chronically depressed individuals.
Adams GC, Wrath AJ, von Dewitz B, Marciniuk K, Roesler A, Napper S.
Psychoneuroendocrinology; 2020 Oct 30; 120():104778. PubMed ID: 32585509
[Abstract] [Full Text] [Related]
19. Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder.
Ruhé HG, Khoenkhoen SJ, Ottenhof KW, Koeter MW, Mocking RJ, Schene AH.
Psychoneuroendocrinology; 2015 Feb 30; 52():261-71. PubMed ID: 25544738
[Abstract] [Full Text] [Related]
20. Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.
Doolin K, Farrell C, Tozzi L, Harkin A, Frodl T, O'Keane V.
Int J Mol Sci; 2017 Oct 24; 18(10):. PubMed ID: 29064428
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
